Quote | Terns Pharmaceuticals Inc. (NASDAQ:TERN)
Last: | $8.875 |
---|---|
Change Percent: | 3.92% |
Open: | $8.63 |
Close: | $8.54 |
High: | $8.93 |
Low: | $8.33 |
Volume: | 118,693 |
Last Trade Date Time: | 07/23/2024 03:00:00 am |
News | Terns Pharmaceuticals Inc. (NASDAQ:TERN)
2024-07-20 09:30:00 ET Eli Lilly and Novo Nordisk are, for now, the undisputed champions of the market for weight-loss medicines. Thanks to the outrageous popularity of Lilly's drug Zepbound and Novo's product Wegovy, the biggest contest of the moment will go to whoever can ramp up ...
2024-07-17 00:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Message Board Posts | Terns Pharmaceuticals Inc. (NASDAQ:TERN)
Subject | By | Source | When |
---|---|---|---|
June 25, 2007 | was thesauceman | investorshub | 06/25/2007 5:24:17 PM |
Still holding and waiting for that White Knight | followinsnsr | investorshub | 06/08/2007 12:10:56 AM |
Motorola to Acquire Terayon Communication Systems | midastouch017 | investorshub | 04/23/2007 1:04:01 PM |
Rumor has it that Motorola will announce the | realfast95 | investorshub | 04/22/2007 6:52:29 PM |
Perhaps in the next 3 weeks. DEF14A is | realfast95 | investorshub | 04/15/2007 12:01:54 AM |
News, Short Squeeze, Breakout and More Instantly...
Terns Pharmaceuticals Inc. Company Name:
TERN Stock Symbol:
NASDAQ Market:
Terns Pharmaceuticals Inc. Website:
2024-07-20 09:30:00 ET Eli Lilly and Novo Nordisk are, for now, the undisputed champions of the market for weight-loss medicines. Thanks to the outrageous popularity of Lilly's drug Zepbound and Novo's product Wegovy, the biggest contest of the moment will go to whoever can ramp up ...
2024-07-17 00:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
FOSTER CITY, Calif., June 21, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including o...